\chapter{Suppl\texorpdfstring{ementary}{.} material for Chap\texorpdfstring{ter}{.}
\getrefnumber{ch:Integration}}\label{ch:SupplIntegration}
%\chaptermark{Supplementary material for \getrefnumber{ch:Integration}}

\begin{figure}[!htpb]
    \includegraphics[scale=0.8]{integration/DFtest2.pdf}\centering
    \vspace{-3.5mm}
    \caption[Distribution of Pearson and Spearman correlation coefficients
    for same-tissue proteomic and transcriptomic pairs
    versus random tissue pairs (untransformed data)]{\label{fig:TestSigUnlog}%
    \textbf{Distribution of Pearson and Spearman correlation coefficients
    for same-tissue proteomic and transcriptomic pairs versus random tissue
    pairs (untransformed data).}}
\end{figure}


\pagestyle{plain}
\small

\begin{landscape}
    \begin{longtable}{@{}llllll@{}}%[]%\centering
    \caption{Found proteins without a counterpart in the transcriptomic data}\label{tab:protNoTrans}\\
\toprule
Set & ENSEMBL (76) ID & Gene name & Biotype & Description & \begin{tabular}[c]{@{}l@{}}Source and \\ Accessing number\end{tabular} \\* \midrule
\endfirsthead
    \caption[]{Found proteins without a counterpart in the transcriptomic data}\\
\toprule
Set & ENSEMBL (76) ID & Gene name & Biotype & Description & \begin{tabular}[c]{@{}l@{}}Source and \\ Accessing number\end{tabular} \\* \midrule
\endhead
%
\bottomrule
\endfoot
%
\endlastfoot
%
a, b, c, d & ENSG00000173349 & SFT2D3 & p.\ coding & SFT2 domain containing 3 & \begin{tabular}[c]{@{}l@{}}HGNC Symbol \\ Acc: 28767\end{tabular} \\
a, b & ENSG00000198788 & MUC2 & \begin{tabular}[c]{@{}l@{}}processed\\ transcript\end{tabular} & \begin{tabular}[c]{@{}l@{}}mucin 2, \\ oligomeric mucus/gel-forming\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc: 7512\end{tabular} \\
a, b, c, d & ENSG00000223953 & C1QTNF5 & p.\ coding & \begin{tabular}[c]{@{}l@{}}C1q and tumor necrosis\\ factor related protein 5\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:14344\end{tabular} \\
a, b & ENSG00000256453 & DND1 & p.\ coding & \begin{tabular}[c]{@{}l@{}}DND microRNA-mediated \\ repression inhibitor\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:23799\end{tabular} \\
a, b, c, d & ENSG00000262664 & OVCA2 & p.\ coding & \begin{tabular}[c]{@{}l@{}}ovarian tumor suppressor\\ candidate 2\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:24203\end{tabular} \\
b & ENSG00000163157 & TMOD4 & p.\ coding & tropomodulin 4 (muscle) & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:11874\end{tabular} \\
b & ENSG00000203618 & GP1BB & p.\ coding & \begin{tabular}[c]{@{}l@{}}glycoprotein Ib (platelet), \\ beta polypeptide\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:4440\end{tabular} \\
b & ENSG00000251322 & SHANK3 & \begin{tabular}[c]{@{}l@{}}processed\\ transcript\end{tabular} & \begin{tabular}[c]{@{}l@{}}SH3 and \\ multiple ankyrin repeat domains 3\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:14294\end{tabular} \\
c, d & ENSG00000105371 & ICAM4 & p.\ coding & \begin{tabular}[c]{@{}l@{}}intercellular adhesion molecule 4 \\ (Landsteiner-Wiener blood group)\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:5347\end{tabular} \\
c & ENSG00000164708 & PGAM2 & p.\ coding & phosphoglycerate mutase 2 (muscle) & \begin{tabular}[c]{@{}l@{}}HGNC Symbol \\ Acc:8889\end{tabular} \\
c, d & ENSG00000181404 & XXyac-YRM2039.2 & \begin{tabular}[c]{@{}l@{}}unprocesssed\\ pseudogene\end{tabular} &  &  \\
c, d & ENSG00000183336 & BOLA2 & p.\ coding & bolA family member 2 & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:29488\end{tabular} \\
c & ENSG00000196101 & HLA-DRB3 & p.\ coding & \begin{tabular}[c]{@{}l@{}}major histocompatibility complex, \\ class II, DR beta 3\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:4951\end{tabular} \\
c & ENSG00000203618 & GP1BB &  & \begin{tabular}[c]{@{}l@{}}glycoprotein Ib (platelet), \\ beta polypeptide\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:4440\end{tabular} \\
c, d & ENSG00000206203 & TSSK2 & p.\ coding & testis-specific serine kinase 2 & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:1140\end{tabular} \\
c, d & \begin{tabular}[c]{@{}c@{}}ENSG00000206240,\\ ENSG00000206306\end{tabular} & HLA-DRB1 & p.\ coding & \begin{tabular}[c]{@{}l@{}}major histocompatibility complex, \\ class II, DR beta 1\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:4948\end{tabular} \\
c, d & ENSG00000206305 & HLA-DQA1 &  & \begin{tabular}[c]{@{}l@{}}major histocompatibility complex,\\ class II, DQ alpha 1\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:4942\end{tabular} \\
c, d & \begin{tabular}[c]{@{}c@{}}ENSG00000206450,\\ ENSG00000223532\end{tabular} & HLA-B & p.\ coding & \begin{tabular}[c]{@{}l@{}}major histocompatibility complex, \\ class I, B\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol \\ Acc:4932\end{tabular} \\
c, d & ENSG00000225691 & HLA-C & p.\ coding & \begin{tabular}[c]{@{}l@{}}major histocompatibility complex, \\ class I, C\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:4933\end{tabular} \\
c, d & \begin{tabular}[c]{@{}c@{}}ENSG00000206505,\\ ENSG00000224320,\\ ENSG00000227715,\\ ENSG00000235657,\\ ENSG00000223980,\\ ENSG00000229215\end{tabular} & HLA-A & p.\ coding & \begin{tabular}[c]{@{}l@{}}major histocompatibility complex,\\ class I, A\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:4931\end{tabular} \\
c, d & ENSG00000211594 & IGKJ4 & IG J gene & immunoglobulin kappa joining 4 & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:5722\end{tabular} \\
c, d & ENSG00000211595 & IGKJ3 & IG J gene & immunoglobulin kappa joining 3 & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:5721\end{tabular} \\
c & ENSG00000213402 & PTPRCAP & p.\ coding & \begin{tabular}[c]{@{}l@{}}protein tyrosine phosphatase,\\ receptor type, C-associated protein\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:9667\end{tabular} \\
c & ENSG00000215695 & RSC1A1 & p.\ coding & \begin{tabular}[c]{@{}l@{}}regulatory solute carrier protein, \\ family 1, member 1\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:10458\end{tabular} \\
c, d & ENSG00000227357 & HLA-DRB4 & p.\ coding & \begin{tabular}[c]{@{}l@{}}major histocompatibility complex, \\ class II, DR beta 4\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:4952\end{tabular} \\
c, d & ENSG00000231021 & HLA-DRB4 & p.\ coding & \begin{tabular}[c]{@{}l@{}}major histocompatibility complex,\\ class II, DR beta 4\end{tabular} & \begin{tabular}[c]{@{}l@{}}RefSeq mRNA\\ Acc:NM\_021983\end{tabular} \\
c, d & ENSG00000231286 & HLA-DQB1 & p.\ coding & \begin{tabular}[c]{@{}l@{}}major histocompatibility complex, \\ class II, DQ beta 1\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:4944\end{tabular} \\
c, d & ENSG00000231679 & HLA-DRB3 & p.\ coding & \begin{tabular}[c]{@{}l@{}}major histocompatibility complex,\\ class II, DR beta 3\end{tabular} & \begin{tabular}[c]{@{}l@{}}RefSeq mRNA\\ Acc:NM\_022555\end{tabular} \\
c, d & ENSG00000256453 & DND1 & p.\ coding & \begin{tabular}[c]{@{}l@{}}DND microRNA-mediated \\ repression inhibitor\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:23799\end{tabular} \\
c & ENSG00000263353 & CH17-118O6.1 & \begin{tabular}[c]{@{}l@{}}processed \\ transcript\end{tabular} &  &  \\
c, d & ENSG00000276938 & FAM157A & p.\ coding & \begin{tabular}[c]{@{}l@{}}Homo sapiens family with \\ sequence similarity 157, member A\end{tabular} & \begin{tabular}[c]{@{}l@{}}RefSeq mRNA\\ Acc:NM\_001145248\end{tabular} \\
c, d & ENSG00000277656 & GSTT1 & p.\ coding & glutathione S-transferase theta 1 & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:4641\end{tabular} \\
c, d & ENSG00000277897 & GSTT2 & p.\ coding &  &  \\
d & ENSG00000105507 & CABP5 & p.\ coding & calcium binding protein 5 & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:3714\end{tabular} \\
d & ENSG00000105954 & NPVF & p.\ coding & neuropeptide VF precursor & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:13782\end{tabular} \\
d & ENSG00000142539 & CTD-2545M3.6 & p.\ coding &  &  \\
d & ENSG00000147896 & IFNK & p.\ coding & interferon, kappa & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:21714\end{tabular} \\
d & ENSG00000148136 & OR13C4 & p.\ coding & \begin{tabular}[c]{@{}l@{}}olfactory receptor, family 13, \\ subfamily C, member 4\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:4722\end{tabular} \\
d & ENSG00000163157 & TMOD & p.\ coding & tropomodulin 4 (muscle) & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:11874\end{tabular} \\
d & ENSG00000164708 & PGAM2 & p.\ coding & \begin{tabular}[c]{@{}l@{}}phosphoglycerate mutase 2\\ (muscle)\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:8889\end{tabular} \\
d & ENSG00000166884 & OR4D6 & p.\ coding & \begin{tabular}[c]{@{}l@{}}olfactory receptor, family 4, \\ subfamily D, member 6\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:15175\end{tabular} \\
d & ENSG00000169840 & GSX1 & p.\ coding & GS homeobox 1 & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:20374\end{tabular} \\
d & ENSG00000170929 & OR1M1 & p.\ coding & \begin{tabular}[c]{@{}l@{}}olfactory receptor, family 1, \\ subfamily M, member 1\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:8220\end{tabular} \\
d & ENSG00000171053 & PATE1 & p.\ coding & prostate and testis expressed 1 & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:24664\end{tabular} \\
d & ENSG00000171396 & KRTAP4-4 & p.\ coding & keratin associated protein 4-4 & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:16928\end{tabular} \\
d & ENSG00000172155 & LCE1D & p.\ coding & late cornified envelope 1D & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:29465\end{tabular} \\
d & ENSG00000176239 & OR51B6 & p.\ coding & \begin{tabular}[c]{@{}l@{}}olfactory receptor, family 51, \\ subfamily B, member 6\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:19600\end{tabular} \\
d & ENSG00000182346 & DAOA & p.\ coding & D-amino acid oxidase activator & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:21191\end{tabular} \\
d & ENSG00000182591 & KRTAP11-1 & p.\ coding & keratin associated protein 11-1 & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:18922\end{tabular} \\
d & ENSG00000184321 & OR51J1 & p.\ coding & \begin{tabular}[c]{@{}l@{}}olfactory receptor, family 51, \\ subfamily J, member 1\\ (gene/pseudogene)\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:14856\end{tabular} \\
d & ENSG00000187173 & LCE2A & p.\ coding & late cornified envelope 2A & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:29469\end{tabular} \\
d & ENSG00000187766 & KRTAP10-8 & p.\ coding & keratin associated protein 10-8 & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:20525\end{tabular} \\
d & ENSG00000196101 & HLA-DRB3 & p.\ coding & \begin{tabular}[c]{@{}l@{}}major histocompatibility complex, \\ class II, DR beta 3\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:4951\end{tabular} \\
d & ENSG00000203618 & GP1BB & p.\ coding & \begin{tabular}[c]{@{}l@{}}glycoprotein Ib (platelet), \\ beta polypeptide\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:4440\end{tabular} \\
d & ENSG00000203818 & HIST2H3PS2 & p.\ coding & \begin{tabular}[c]{@{}l@{}}histone cluster 2, H3,\\ pseudogene 2\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:32060\end{tabular} \\
d & ENSG00000205883 & DEFB135 & p.\ coding & defensin, beta 135 & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:32400\end{tabular} \\
d & ENSG00000206452 & HLA-C & p.\ coding & \begin{tabular}[c]{@{}l@{}}major histocompatibility complex, \\ class I, C\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:4933\end{tabular} \\
d & ENSG00000211831 & TRAJ61 & TR J gene & \begin{tabular}[c]{@{}l@{}}T cell receptor alpha joining 61\\ (non-functional)\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:12094\end{tabular} \\
d & ENSG00000211835 & TRAJ56 & TR J gene & T cell receptor alpha joining 56 & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:12088\end{tabular} \\
d & ENSG00000213316 & LTC4S & p.\ coding & leukotriene C4 synthase & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:6719\end{tabular} \\
d & ENSG00000213402 & PTPRCAP & p.\ coding & \begin{tabular}[c]{@{}l@{}}protein tyrosine phosphatase, \\ receptor type, C-associated protein\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:9667\end{tabular} \\
d & ENSG00000215695 & RSC1A1 & p.\ coding & \begin{tabular}[c]{@{}l@{}}regulatory solute carrier protein, \\ family 1, member 1\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:10458\end{tabular} \\
d & ENSG00000224902 & GAGE12H & p.\ coding & G antigen 12H & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:31908\end{tabular} \\
d & ENSG00000233732 & IGHV3OR16-10 & IG V gene & \begin{tabular}[c]{@{}l@{}}immunoglobulin heavy variable 3\\ OR16-10 (non-functional)\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:5634\end{tabular} \\
d & ENSG00000249209 & AP000304.12 & p.\ coding &  &  \\
d & ENSG00000249730 & OR10J4 & \begin{tabular}[c]{@{}l@{}}polymorphic\\ pseudogene\end{tabular} & \begin{tabular}[c]{@{}l@{}}olfactory receptor, \\ family 10, subfamily J,\\ member 4 (gene/pseudogene)\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:15408\end{tabular} \\
d & ENSG00000253148 & RGS21 & p.\ coding & regulator of G-protein signaling 21 & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:26839\end{tabular} \\
d & ENSG00000255009 & UBTFL1 & \begin{tabular}[c]{@{}l@{}}processed \\ pseudogene\end{tabular} & \begin{tabular}[c]{@{}l@{}}upstream binding transcription factor,\\ RNA polymerase I-like 1\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:14533\end{tabular} \\
d & ENSG00000255472 & RP11-998D10.1 & p.\ coding & uncharacterized protein & \begin{tabular}[c]{@{}l@{}}UniProtKB/TrEMBL\\ Acc:E9PR74\end{tabular} \\
d & ENSG00000259490 & IGHV3OR15-7 & IG V gene & \begin{tabular}[c]{@{}l@{}}immunoglobulin heavy variable 3\\ OR15-7 (pseudogene)\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:5633\end{tabular} \\
d & ENSG00000263353 & CH17-118O6.1 & \begin{tabular}[c]{@{}l@{}}processed\\ transcript\end{tabular} &  &  \\
d & ENSG00000270467 & IGHV3OR16-12 & IG V gene & \begin{tabular}[c]{@{}l@{}}immunoglobulin heavy variable 3\\ OR16-12 (non-functional)\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:5636\end{tabular} \\
d & ENSG00000270472 & IGHV3OR16-9 & IG V gene & \begin{tabular}[c]{@{}l@{}}immunoglobulin heavy variable 3\\ OR16-9 (non-functional)\end{tabular} & \begin{tabular}[c]{@{}l@{}}HGNC Symbol\\ Acc:5644\end{tabular} \\*
    \bottomrule
\end{longtable}
\end{landscape}

\pagestyle{scrheadings}
\normalsize

\pagestyle{plain}
\begin{landscape}
\begin{longtable}{@{}ccccccccc@{}}
\caption[Summary of Pearson and Spearman correlations
between proteomics and transcriptomics]{\label{tab:pvalueCorrSP}%
\textbf{Summary of Pearson and Spearman correlation coefficients
between proteomics and transcriptomics} across several data combinations.
See also \Cref{fig:TestSig}.}\\
\toprule
\multicolumn{2}{c}{} &  &  &  &  & \multicolumn{2}{c}{Mean correlation of} &  \\* \cmidrule(lr){7-8}
\multicolumn{2}{c}{\multirow{-2}{*}{Datasets}} & \multirow{-2}{*}{\begin{tabular}[c]{@{}c@{}}Number \\ of tissues\end{tabular}} & \multirow{-2}{*}{\begin{tabular}[c]{@{}c@{}}Quantification\\ methods\end{tabular}} & \multirow{-2}{*}{\begin{tabular}[c]{@{}c@{}}Scaled data\\ $\log_2(x+1)$\end{tabular}} & \multirow{-2}{*}{\begin{tabular}[c]{@{}c@{}}Correlation\\ method\end{tabular}} & Same-tissue pairs & Different tissues pairs & \multirow{-2}{*}{p-value} \\* \midrule
\endfirsthead
\caption[]{\textbf{Summary of Pearson and Spearman correlation coefficients
between proteomics and transcriptomics} across several data combinations.
See also \Cref{fig:TestSig}.}\\
\toprule
\multicolumn{2}{c}{} &  &  &  &  & \multicolumn{2}{c}{Mean correlation of} &  \\* \cmidrule(lr){7-8}
\multicolumn{2}{c}{\multirow{-2}{*}{Datasets}} & \multirow{-2}{*}{\begin{tabular}[c]{@{}c@{}}Number \\ of tissues\end{tabular}} & \multirow{-2}{*}{\begin{tabular}[c]{@{}c@{}}Quantification\\ methods\end{tabular}} & \multirow{-2}{*}{\begin{tabular}[c]{@{}c@{}}Scaled data\\ $\log_2(x+1)$\end{tabular}} & \multirow{-2}{*}{\begin{tabular}[c]{@{}c@{}}Correlation\\ method\end{tabular}} & Same-tissue pairs & Different tissues pairs & \multirow{-2}{*}{p-value} \\* \midrule
\endhead
%
\bottomrule
\endfoot
%
\endlastfoot
%
Pandey et al. & Uhlén et al. & 12 & Top3 x HTSeq & True & Spearman & 0.51 & 0.37 & 4.66e-07 \\
Pandey et al. & GTEx & 12 & Top3 x HTSeq & True & Spearman & 0.5 & 0.37 & 7.379e-07 \\
{\color[HTML]{9B9B9B} Uhlén et al.} & {\color[HTML]{9B9B9B} GTEx} & {\color[HTML]{9B9B9B} 12} & {\color[HTML]{9B9B9B} HTSeq x HTSeq} & {\color[HTML]{9B9B9B} True} & {\color[HTML]{9B9B9B} Spearman} & {\color[HTML]{9B9B9B} 0.91} & {\color[HTML]{9B9B9B} 0.66} & {\color[HTML]{9B9B9B} \textless\ 2.2e-16} \\
Pandey et al. & Uhlén et al. & 15 & Top3 x HTSeq & True & Spearman & 0.5 & 0.38 & 2.659e-08 \\
Pandey et al. & Uhlén et al. & 12 & Top3 x HTSeq & True & Pearson & 0.11 & 0.06 & 0.03696 \\
Pandey et al. & GTEx & 12 & Top3 x HTSeq & True & Pearson & 0.12 & 0.07 & 0.02895 \\
{\color[HTML]{9B9B9B} Uhlén et al.} & {\color[HTML]{9B9B9B} GTEx} & {\color[HTML]{9B9B9B} 12} & {\color[HTML]{9B9B9B} HTSeq x HTSeq} & {\color[HTML]{9B9B9B} True} & {\color[HTML]{9B9B9B} Pearson} & {\color[HTML]{9B9B9B} 0.93} & {\color[HTML]{9B9B9B} 0.68} & {\color[HTML]{9B9B9B} \textless\ 2.2e-16} \\
Pandey et al. & Uhlén et al. & 15 & Top3 x HTSeq & True & Pearson & 0.1 & 0.06 & 0.02271 \\
Pandey et al. & Uhlén et al. & 12 & PPKM x HTSeq & True & Spearman & 0.52 & 0.42 & 4.795e-05 \\
Pandey et al. & GTEx & 12 & PPKM x HTSeq & True & Spearman & 0.52 & 0.43 & 8.475e-05 \\
{\color[HTML]{9B9B9B} Uhlén et al.} & {\color[HTML]{9B9B9B} GTEx} & {\color[HTML]{9B9B9B} 12} & {\color[HTML]{9B9B9B} HTSeq x HTSeq} & {\color[HTML]{9B9B9B} True} & {\color[HTML]{9B9B9B} Spearman} & {\color[HTML]{9B9B9B} 0.92} & {\color[HTML]{9B9B9B} 0.72} & {\color[HTML]{9B9B9B} \textless\ 2.2e-16} \\
Pandey et al. & Uhlén et al. & 15 & PPKM x HTSeq & True & Spearman & 0.52 & 0.43 & 8.422e-06 \\
Pandey et al. & Uhlén et al. & 12 & PPKM x HTSeq & True & Pearson & 0.5 & 0.37 & 0.0004002 \\
Pandey et al. & GTEx & 12 & PPKM x HTSeq & True & Pearson & 0.5 & 0.41 & 0.0003306 \\
{\color[HTML]{9B9B9B} Uhlén et al.} & {\color[HTML]{9B9B9B} GTEx} & {\color[HTML]{9B9B9B} 12} & {\color[HTML]{9B9B9B} HTSeq x HTSeq} & {\color[HTML]{9B9B9B} True} & {\color[HTML]{9B9B9B} Pearson} & {\color[HTML]{9B9B9B} 0.94} & {\color[HTML]{9B9B9B} 0.73} & {\color[HTML]{9B9B9B} \textless\ 2.2e-16} \\
Pandey et al. & Uhlén et al. & 15 & PPKM x HTSeq & True & Pearson & 0.49 & 0.4 & 9.941e-05 \\* \midrule
Pandey et al. & Uhlén et al. & 12 & Top3 x HTSeq & False & Spearman & 0.51 & 0.37 & 4.66e-07 \\
Pandey et al. & GTEx & 12 & Top3 x HTSeq & False & Spearman & 0.5 & 0.37 & 7.379e-07 \\
{\color[HTML]{9B9B9B} Uhlén et al.} & {\color[HTML]{9B9B9B} GTEx} & {\color[HTML]{9B9B9B} 12} & {\color[HTML]{9B9B9B} HTSeq x HTSeq} & {\color[HTML]{9B9B9B} False} & {\color[HTML]{9B9B9B} Spearman} & {\color[HTML]{9B9B9B} 0.91} & {\color[HTML]{9B9B9B} 0.66} & {\color[HTML]{9B9B9B} \textless\ 2.2e-16} \\
Pandey et al. & Uhlén et al. & 15 & Top3 x HTSeq & False & Spearman & 0.5 & 0.38 & 2.66e-08 \\
Pandey et al. & Uhlén et al. & 12 & Top3 x HTSeq & False & Pearson & 0.17 & 0.09 & 0.022 \\
Pandey et al. & GTEx & 12 & Top3 x HTSeq & False & Pearson & 0.17 & 0.1 & 0.015 \\
{\color[HTML]{9B9B9B} Uhlén et al.} & {\color[HTML]{9B9B9B} GTEx} & {\color[HTML]{9B9B9B} 12} & {\color[HTML]{9B9B9B} HTSeq x HTSeq} & {\color[HTML]{9B9B9B} False} & {\color[HTML]{9B9B9B} Pearson} & {\color[HTML]{9B9B9B} 0.92} & {\color[HTML]{9B9B9B} 0.64} & {\color[HTML]{9B9B9B} \textless\ 2.2e-16} \\
Pandey et al. & Uhlén et al. & 15 & Top3 x HTSeq & False & Pearson & 0.16 & 0.1 & 0.012 \\
Pandey et al. & Uhlén et al. & 12 & PPKM x HTSeq & False & Spearman & 0.52 & 0.42 & 4.795e-05 \\
Pandey et al. & GTEx & 12 & PPKM x HTSeq & False & Spearman & 0.52 & 0.43 & 8.475e-05 \\
{\color[HTML]{9B9B9B} Uhlén et al.} & {\color[HTML]{9B9B9B} GTEx} & {\color[HTML]{9B9B9B} 12} & {\color[HTML]{9B9B9B} HTSeq x HTSeq} & {\color[HTML]{9B9B9B} False} & {\color[HTML]{9B9B9B} Spearman} & {\color[HTML]{9B9B9B} 0.92} & {\color[HTML]{9B9B9B} 0.72} & {\color[HTML]{9B9B9B} \textless\ 2.2e-16} \\
Pandey et al. & Uhlén et al. & 15 & PPKM x HTSeq & False & Spearman & 0.52 & 0.43 & 8.422e-06 \\
Pandey et al. & Uhlén et al. & 12 & PPKM x HTSeq & False & Pearson & 0.55 & 0.43 & 1.059e-06 \\
Pandey et al. & GTEx & 12 & PPKM x HTSeq & False & Pearson & 0.56 & 0.45 & 2.026e-06 \\
{\color[HTML]{9B9B9B} Uhlén et al.} & {\color[HTML]{9B9B9B} GTEx} & {\color[HTML]{9B9B9B} 12} & {\color[HTML]{9B9B9B} HTSeq x HTSeq} & {\color[HTML]{9B9B9B} False} & {\color[HTML]{9B9B9B} Pearson} & {\color[HTML]{9B9B9B} 0.93} & {\color[HTML]{9B9B9B} 0.69} & {\color[HTML]{9B9B9B} \textless\ 2.2e-16} \\
Pandey et al. & Uhlén et al. & 15 & PPKM x HTSeq & False & Pearson & 0.55 & 0.45 & 1.061e-07 \\* \bottomrule
\end{longtable}
\end{landscape}

\pagestyle{scrheadings}


\begin{figure}[!htpb]
    \includegraphics[scale=0.75]{integration/Kidney_scattplot_Q1.pdf}\centering
    \caption[Scatterplot of protein (Pandey et al.\ --- Top3 quantification)
    and \mRNA\ (Uhlén et al.) expression for Kidney]{\label{fig:ScatKidQ1}%
    \textbf{Scatterplot of protein (Pandey et al.\ --- Top3 quantification)
    and \mRNA\ (Uhlén et al.) expression for Kidney.}}
\end{figure}




\begin{figure}[!htb]
    \includegraphics[scale=0.7]{integration/TissuePairsQ3T15HeatmapPandey.pdf}\centering
    \caption[Heatmap]{\label{fig:heatmapPandeyTissuePairs}\textbf{<++>}<++>}
\end{figure}

\begin{figure}[!htb]
    \includegraphics[scale=0.7]{integration/TissuePairsQ3T15HeatmapUhlen05.pdf}\centering
    \caption[Heatmap]{\label{fig:heatmapUhlenTissuePairs05}\textbf{<++>}<++>}
\end{figure}


\section{Hypergeometric test}\label{sec:hypergeometricTest}

The hypergeometric test measures the statistical significance of
randomly sampling $k$ successes out of $n$ draws (without replacement)
from a population of $N$ that contains $K$ successes.
It uses the hypergeometric distribution
and equates to the one-sided Fisher's exact test.

Depending on whether the test is about an over or under-representation,
the p-value is the probability of drawing respectively a minimum or a maximum
of $k$ successes.

In \Cref{sec:TSprotMrna},
I consider as success when a \gls{TS} \mRNA\ is among the $n$ \gls{TS} proteins
and I test if the number of successes is greater than
the expected number for a random sampling.

See also \citet{Johnson2005-mf} for more examples using this test.

%\begin{figure}[!htbp]
%    \includegraphics[scale=0.9]{integration/overlapRatioPvalPUQ15Q3.pdf}\centering
%    \caption[p-values associated to the Jaquard indices]{\label{fig:JaccardPvalues}\label{fig:pJacquard}%
%    \textbf{p-value associated to the Jaquard indices.}They have been computed with hypergeometric test.}
%\end{figure}


\clearpage



\normalsize


\pagestyle{scrheadings}

